Diminished expression of β2-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb/IIIa-mediated immune thrombocytopenia-Reference-Cited by-同舟云学术

Diminished expression of β2-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb/IIIa-mediated immune thrombocytopenia

Published:2017-12-29 Issue:4 Volume:97 Page:641-654
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Zhu Xiaolu,Zhang Jiamin,Wang Qianming,Fu Haixia,Chang Yingjun,Kong Yuan,Lv Meng,Xu Lanping,Liu Kaiyan,Huang Xiaojun,Zhang Xiaohui

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Beijing Municipal Science and Technology Commission

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3215-3/fulltext.html

Reference76 articles.

1. Cines DB, Bussel JB, Liebman HA, Luning PE (2009) The ITP syndrome: pathogenic and clinical diversity. Blood 113(26):6511–6521. https://doi.org/10.1182/blood-2009-01-129155

2. Zhao C, Li X, Zhang F, Wang L, Peng J, Hou M (2008) Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica 93(9):1428–1430. https://doi.org/10.3324/haematol.12889

3. Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, Peng J, Hou M (2006) Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 76(5):427–431. https://doi.org/10.1111/j.1600-0609.2005.00622.x

4. Li J, van der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, Vadasz B, Carrim N, Grozovsky R, Ruan M, Zhu L, Zeng Q, Tao L, Zhai ZM, Peng J, Hou M, Leytin V, Freedman J, Hoffmeister KM, Ni H (2015) Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 6:7737. https://doi.org/10.1038/ncomms8737

5. Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M (2015) Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets 26(5):495–497. https://doi.org/10.3109/09537104.2014.948838

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of the complement system in immune thrombocytopenia: review of the literature;Immunological Medicine;2023-05-26

2. Therapeutic potential of MSCs and MSC-derived extracellular vesicles in immune thrombocytopenia;Stem Cell Research & Therapy;2023-04-12

3. Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia;International Journal of Molecular Sciences;2023-02-23

4. Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study;Platelets;2023-01-13

5. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?;Haematologica;2019-05-24